Apellis Pharmaceuticals Inc (NASDAQ:APLS) gets upgraded to Overweight by JPMorgan Chase & Co.

Apellis Pharmaceuticals Inc (NASDAQ:APLS) gets upgraded to Overweight by JPMorgan Chase & Co.

Jul 12, 2019 (Market Exclusive via COMTEX) —

Analyst Ratings For Apellis Pharmaceuticals Inc (NASDAQ:APLS)

Today, Apellis Pharmaceuticals Inc (NASDAQ:APLS) stock received an upgrade by JPMorgan Chase & Co. from Neutral to Overweight.

There are 7 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.

The current consensus rating on Apellis Pharmaceuticals Inc (NASDAQ:APLS) is Buy with a consensus target price of $43.2857 per share, a potential 65.72% upside.

Some recent analyst ratings include

7/12/2019-Apellis Pharmaceuticals Inc (NASDAQ:APLS) gets upgraded to Overweight by JPMorgan Chase & Co. 7/9/2019-Apellis Pharmaceuticals Inc (NASDAQ:APLS) has coverage initiated with a Outperform rating and $52.00 price target 6/16/2019-Apellis Pharmaceuticals Inc (NASDAQ:APLS) had its Buy rating reiterated by Cowen with a $40.00 price target 5/8/2019-Apellis Pharmaceuticals Inc (NASDAQ:APLS) had its Buy rating reiterated by Cantor Fitzgerald with a $52.00 price target 3/28/2019-Apellis Pharmaceuticals Inc (NASDAQ:APLS) has coverage initiated with a Outperform ➝ Outperform rating and $45.00 price target 1/8/2019-Apellis Pharmaceuticals Inc (NASDAQ:APLS) has coverage initiated with a Buy rating and $40.00 price target On 3/11/2019 Morningside Venture Investment, Major Shareholder, bought 441,176 with an average share price of $17.00 per share and the total transaction amounting to $7,499,992.00. On 9/21/2018 Morningside Venture Investment, Major Shareholder, bought 81,323 with an average share price of $19.48 per share and the total transaction amounting to $1,584,172.04. On 9/19/2018 Morningside Venture Investment, Major Shareholder, bought 140,000 with an average share price of $18.34 per share and the total transaction amounting to $2,567,600.00. On 9/14/2018 David O Watson, General Counsel, sold 15,776 with an average share price of $18.78 per share and the total transaction amounting to $296,273.28. On 5/24/2018 Lukas Scheibler, Insider, bought 2,935 with an average share price

Read More Here...

Bookmark the permalink.